Chicagoland has claimed a spot among the top biopharma hubs in the U.S., based on patent filings, National Institutes of Health (NIH) funding and real estate market data. R&D World’s analysis highlights the region’s prominence in life sciences, which has been boosted by the Chan Zuckerberg Initiative and the Chicago Biomedical Consortium Hub for Innovative Technology and Entrepreneurship in the Sciences (CITIES).
< BACK TO MAIN NEWS PAGE